Company news
Kda Group Inc. (TSXV:KDA) news
Kda Group Inc. news releases on 6ix. Latest, Aug 26, 2026: KDA GROUP APPOINTS LOUISE POTVIN TO ITS BOARD OF DIRECTORS
Press releases & updates
KDA GROUP APPOINTS LOUISE POTVIN TO ITS BOARD OF DIRECTORS
August 26, 2026
AN INDEPENDENT EVALUATION CONFIRMS THE CLINICAL AND ORGANIZATIONAL BENEFITS OF THE MEDHERIZE PLATFORM IN BREAST ONCOLOGY
June 18, 2026
KDA GROUP COMPLETES DEBT SETTLEMENT
May 29, 2026
KDA GROUP ANNOUNCES RESULTS OF SHAREHOLDERS' ANNUAL GENERAL MEETING AND THE SETTLEMENT OF JUDICIAL CLAIMS
May 5, 2026
KDA GROUP ANNOUNCES THE APPOINTMENT OF MARTIN KIROUAC AS CHIEF TECHNOLOGY OFFICER OF ITS SUBSIDIARY GROUPE TECHNOLOGIQUE KDA
April 9, 2026
KDA GROUP ANNOUNCES THE ACQUISITION OF THE MINORITY INTEREST IN ITS SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.
March 24, 2026
KDA ANNOUNCES THE APPOINTMENT OF A NEW PRESIDENT AND CHIEF EXECUTIVE OFFICER
March 2, 2026
UPDATE OF THE TRANSACTION ANNOUNCED ON NOVEMBER 25, 2025, FOR THE ACQUISITION OF THE MINORITY INTEREST IN THE SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.
December 24, 2025
KDA GROUP ANNOUNCES A COLLABORATION TO INTEGRATE NEW CLINICAL ALERTS INTO THE MEDHERIZE PLATFORM TO SUPPORT THE ADOPTION OF NEXT-GENERATION SEQUENCING FOR BREAST CANCER PATIENTS
December 22, 2025
KDA GROUP ANNOUNCES PARTNERSHIP AGREEMENT WITH CHU DE QUÉBEC-UNIVERSITÉ LAVAL FOR THE DEPLOYMENT OF MEDHERIZE
December 3, 2025
KDA GROUP ANNOUNCES PARTNERSHIP AGREEMENT WITH CHU DE QUÉBEC-UNIVERSITÉ LAVAL FOR THE DEPLOYMENT OF MEDHERIZE
December 3, 2025
KDA GROUP DEPLOYS MEDHERIZE ACROSS COMMUNITY PHARMACIES: A MAJOR STEP FORWARD IN THE MANAGEMENT OF ORAL ANTICANCER THERAPIES
December 1, 2025
KDA GROUP ANNOUNCES AGREEMENT TO ACQUIRE MINORITY INTEREST IN ITS SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.
November 25, 2025
KDA GROUP OPENS A U.S. SUBSIDIARY AND ACCELERATES THE GROWTH OF ITS MEDHERIZE SOLUTION
November 17, 2025
KDA GROUP ANNOUNCES CLOSING OF PRIVATE PLACEMENT
May 29, 2025
KDA GROUP RECEIVES DSQ CERTIFICATION FOR ADHERIZE+ PLATFORM -- MEDHERIZE MODULE ENTERS CLINICAL DEPLOYMENT PHASE
May 21, 2025
KDA GROUP REACHES FINAL CERTIFICATION PHASE FOR MEDHERIZE WITH DSQ - DOSSIER SANTÉ QUÉBEC
April 15, 2025
KDA GROUP REACHES FINAL CERTIFICATION PHASE FOR MEDHERIZE WITH DSQ - DOSSIER SANTÉ QUÉBEC
April 15, 2025
KDA GROUP ANNOUNCES RESULTS OF SHAREHOLDERS' ANNUAL GENERAL MEETING
February 24, 2025
GROUPE TECHNOLOGIQUE KDA ANNOUNCES A STRATEGIC COLLABORATION WITH PHARMACIE HORIZON SANTÉ AND DR. ÉRIC POIRIER TO OPTIMIZE ONCOLOGY TREATMENT MANAGEMENT
December 12, 2024
KDA Group Announces an Important Certification Update with the Quebec Health Record / Dossier Sante Quebec
December 3, 2024
Groupe KDA Annonce une Mise a Jour Importante Concernant la Certification avec le Dossier Sante Quebec
December 3, 2024
KDA Group Announces the Appointment of the Honorable Jean Charest as New Strategic Advisor
November 21, 2024
Groupe KDA Annonce L'arrivee de L'honorable Jean Charest comme Nouveau Conseiller Strategique
November 21, 2024
KDA Group Launches Medherize for Specialized Metastatic Breast Cancer Treatment Management
August 1, 2024
Groupe KDA Lance Medherize pour la Gestion des Traitements Specialises du Cancer du Sein Metastatique
August 1, 2024
KDA Group Announces the Development of Medherize, a New Clinical Management Solution for Specialized Medications for Breast Cancer
June 12, 2024
Groupe KDA Annonce le Developpement de Medherize, une Nouvelle Solution de Gestion Clinique des Medicaments Specialises pour le Cancer du Sein
June 12, 2024
KDA Group Announces Results of Shareholders' Annual General and Special Meeting
May 17, 2024
Groupe KDA Annonce Les Resultats De Son Assemblee Generale Et Extraordinaire Des Actionnaires
May 17, 2024
Mise a Jour de la Plateforme Adherize+
March 21, 2024
Adherize+ Platform Update
March 21, 2024
KDA Group Completes Debt Settlement
February 29, 2024
Groupe KDA Complete Un Reglement De Dette
February 29, 2024
KDA Group Announces the Appointments of Yves Marmet as General Manager and Chief Technology Officer and Marie-Helene Pinard as Chief Operating Officer of its Subsidiary Groupe Technologique KDA, and a Debt Settlement
February 22, 2024
Groupe KDA Annonce les Nominations de Yves Marmet comme Directeur General et Chef de la Technologie et de Marie-Helene Pinard comme Chef des Operations de sa Filiale Groupe Technologique KDA, et un Reglement de Dette
February 22, 2024
KDA Group Announces Collaboration With Several Pharmacy Banners
December 20, 2023
GROUPE KDA ANNONCE SA COLLABORATION AVEC PLUSIEURS BANNIERES DE PHARMACIES
December 20, 2023
KDA Group Announces Closing of Private Placement
December 8, 2023
GROUPE KDA ANNONCE LA CLOTURE D'UN PLACEMENT PRIVE
December 8, 2023
Mise a Jour du Groupe KDA
September 22, 2023
KDA Group -- Update
September 22, 2023
KDA Group Announces the Appointment of Michael W. Kinley as Chief Financial Officer
September 5, 2023
GROUPE KDA ANNONCE LA NOMINATION DE MICHAEL W. KINLEY COMME CHEF DE LA DIRECTION FINANCIERE
September 5, 2023
TSX Venture Exchange Stock Maintenance Bulletins
August 3, 2023
KDA Group Completes Acquisition of All ZRX Digital Prescriber Proprietary Rights From ZoomMed
July 28, 2023
GROUPE KDA COMPLETE L'ACQUISITION DE TOUS LES DROITS DE PROPRIETE DU PRESCRIPTEUR NUMERIQUE ZRX DE ZOOMMED
July 28, 2023
KDA Group Announces the Signing of an Agreement with Zoommed Medical Inc. to Expand the Operating Territory of the ZRx Digital Prescriber
June 30, 2023
GROUPE KDA ANNONCE LA SIGNATURE D'UNE ENTENTE AVEC ZOOMMED MEDICAL INC. POUR L'EXPANSION DU TERRITOIRE D'EXPLOITATION DU PRESCRIPTEUR NUMERIQUE ZRX
June 30, 2023
KDA Group Announces Debt Repayment and Two Directors' Resignation
June 29, 2023